Boundless Bio, Inc.

NASDAQ:BOLD

Biotechnology

Healthcare
$2.38 +85.71%

+$1.20 today

Market cap
$56.20M
Beta
0.97
P/E (TTM)
-1.0
EPS (TTM)
-$2.50
52W Low $0.96High $2.75

Volume 0.13M

Average 0.22M

Returns on capital

Boundless Bio, Inc. management

Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.

Return Metrics

ROE, ROIC & ROA over time

Management
Older years hidden. Sign in to unlock

ROE

-59.0%

avg -9.7%

ROIC

-43.0%

avg -42.9%

ROA

-37.1%

avg -38.6%

Analysis

ROA is currently the strongest return metric at -37.1% versus its period average of -38.6%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Leadership

Who runs the company?

Review the executive team, tenure, compensation, and ownership.

Management

Key executives, compensation & ownership

NameTitleCompensationAgeShares OwnedOwnership %

David Hinkle

Senior Vice President of Finance, Controller & Corporate Treasurer—64——

Jessica Oien

President, Principal Executive Officer, Chief Legal Officer & Corporate Secretary—55220.00K0.98%

Meredith Wesley

Chief Human Resources Officer————

Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Jan 23, 2026.

Insider trading

Are insiders buying or selling?

Follow recent insider purchases and sales reported on Form 4.

Insider Trading

SEC Form 4 transactions — last 12 months

Buys

35

$1.97M

Sells

3

$134,031.00

Net Transaction Value

+$1.84M

Net buying

Most Active

TANG KEVIN

36 transactions

Transactions sorted by date, descending.

Open-market insider purchases and sales reported during the last 12 months
Type
Nov 10, 26

TANG KEVIN

Indirect

Buy$597.6
Nov 6, 26

TANG KEVIN

Indirect

Buy$4.1K
Nov 5, 26

TANG KEVIN

Indirect

Buy$20.1K
Nov 4, 26

TANG KEVIN

Indirect

Buy$1.2K
Nov 3, 26

TANG KEVIN

Indirect

Buy$5.4K
Oct 27, 26

TANG KEVIN

Indirect

Buy$25.7K
Oct 26, 26

TANG KEVIN

Indirect

Buy$22.9K
Oct 23, 26

TANG KEVIN

Indirect

Buy$14.8K
Oct 22, 26

TANG KEVIN

Indirect

Buy$13.9K
Oct 20, 26

TANG KEVIN

Indirect

Buy$521.4

1–10 of 38

Summary

Insiders reported 35 buys worth $1.97M and 3 sells worth $134,031.00 over the last 12 months. That adds up to net buying of $1.84M. TANG KEVIN was the most active insider with 36 transactions.

Growth analysis

Is management growing the business?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/AN/A
N/A1 analysts
RevenueN/AN/AN/A
N/A0 analysts
Net IncomeN/AN/AN/A
N/A0 analysts
EBITN/AN/AN/A
N/A0 analysts

Analysis

Analysis will appear once historical growth or forward estimates are available for this company.

Competitors

Who does Boundless Bio, Inc. compete with?

Open similar companies to compare how their management teams allocate capital.

Questions

Management questions

Common questions about BOLD's management, answered from reported figures.

Who manages BOLD?

Boundless Bio, Inc. (BOLD) lists 3 active executives. The top listed executive is David Hinkle, Senior Vice President of Finance, Controller & Corporate Treasurer.

Are BOLD insiders buying or selling?

Recent insider activity shows net buying of $22.44M.